Abstract:A series of new 1,2,4-oxadiazole-based derivatives were synthesized and evaluated for their anti-AD potential. The results revealed that eleven compounds ( 1b , 2a-c , 3b , 4a-c , and 5a-c ) exhibited excellent inhibitory potential against AChE, with IC 50 values ranging from 0.00098 to 0.07920 μM. Their potency was 1.55 to 125.47 times higher than that of donepezil (IC 50 = 0.12297 μM). In contrast, the newly synthesized oxadiazole derivatives with IC 50 values in the range of 16.64 – 70.82 μM exhibited less selectivity towards BuChE when compared to rivastigmine (IC 50 = 5.88 μM). Moreover, oxadiazole derivative 2c (IC 50 = 463.85 μM) was more potent antioxidant than quercetin (IC 50 = 491.23 μM). Compounds 3b (IC 50 = 536.83 μM) and 3c (IC 50 = 582.44 μM) exhibited comparable antioxidant activity to that of quercetin. Oxadiazole derivatives 3b (IC 50 = 140.02 μM) and 4c (IC 50 = 117.43 μM) showed prominent MAO-B inhibitory potential. They were more potent than biperiden (IC 50 = 237.59 μM). Compounds 1a , 1b , 3a , 3c , and 4b exhibited remarkable MAO-A inhibitory potential, with IC 50 values ranging from 47.25 to 129.7 μM. Their potency was 1.1 to 3.03 times higher than that of methylene blue (IC 50 = 143.6 μM). Most of the synthesized oxadiazole derivatives provided significant protection against induced HRBCs lysis, revealing the nontoxic effect of the synthesized compounds, thus making them safe drug candidates. The results unveiled oxadiazole derivatives 2b , 2c , 3b, 4a, 4c , and 5a as multitarget anti-AD agents. The high AChE inhibitory potential can be computationally explained by the synthesized oxadiazole derivatives' significant interactions with the AChE active site. Compound 2b showed good physicochemical properties. All these data suggest that 2b could be considered as a promising candidate for future development.

Design, Synthesis, and Biological Evaluation of 1,3,4-Oxadiazole Derivatives

Synthesis, in Vitro Cholinesterase Inhibition, Molecular Docking, DFT, and ADME Studies of Novel 1,3,4‐oxadiazole‐2‐thiol Derivatives

New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation

Design, synthesis and biological evaluation of 1-aryldonepezil analogues as anti-Alzheimer's disease agents

Inhibition of Acetylcholinesterase with Novel 1, 3, 4, Oxadiazole Derivatives: A Kinetic, In Silico, and In Vitro Approach

Design, synthesis, and bio-evaluation of new isoindoline-1,3-dione derivatives as possible inhibitors of acetylcholinesterase

Design, synthesis and biological evaluation of novel indanones derivatives as potent acetylcholinesterase/monoamine oxidase B inhibitors

Design, synthesis and evaluation of imidazo[1,2-a]pyrazin-8(7H)-one derivatives as acetylcholinesterase inhibitors and antioxidants

Design, synthesis and evaluation of aminothiazole derivatives as potential anti-Alzheimer's candidates

Synthesis, Biological Activity, X-ray Crystallographic, DFT Calculations and Molecular Dynamics Simulation Studies of 2-Phenylthiazole-1,3,5-triazine Derivatives As Potential Cholinesterase Inhibitors

Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors

Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer's disease agents.

Design, Synthesis, and Biological Evaluation of 2-Arylethenylquinoline Derivatives As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Synthesis, Biological Activity, Molecular Docking Studies of a Novel Series of 3-Aryl-7h-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives As the Acetylcholinesterase Inhibitors

Design, Synthesis and Biological Evaluation of New 3,4-Dihydro-2(1<i>H</i>)-Quinolinone-Dithiocarbamate Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease

Design, Synthesis, In Vitro And In Vivo Evaluation Of Benzylpiperidine-Linked 1,3-Dimethylbenzimidazolinones As Cholinesterase Inhibitors Against Alzheimer'S Disease

Design, Synthesis, Biological Evaluation and Molecular Modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] Dioxole-5-carboxamides As Selective Butyrylcholinesterase Inhibitors.

6-acetyl-5H-thiazolo[3,2-a]pyrimidine derivatives as the novel acetylcholinesterase inhibitors: design, synthesis, and biological activity.

Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase/monoamine oxidase B dual inhibitors for the treatment of Alzheimer’s disease

Design, Synthesis, and Biological Evaluation of Carbamate Derivatives of N-salicyloyl Tryptamine As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Synthesis and Biological Evaluation of 5,6-Dihydro-benzo[c] Acridin-7-ol Derivatives As Anti-Alzheimers Disease Drugs